SI2021002T1 - Farmacevtski sestavek, ki vsebuje olmesartan medoksomil - Google Patents
Farmacevtski sestavek, ki vsebuje olmesartan medoksomilInfo
- Publication number
- SI2021002T1 SI2021002T1 SI200731003T SI200731003T SI2021002T1 SI 2021002 T1 SI2021002 T1 SI 2021002T1 SI 200731003 T SI200731003 T SI 200731003T SI 200731003 T SI200731003 T SI 200731003T SI 2021002 T1 SI2021002 T1 SI 2021002T1
- Authority
- SI
- Slovenia
- Prior art keywords
- olmesartan medoxomil
- pharmaceutical composition
- medoxomil
- olmesartan
- subjecting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06009223A EP1891952B1 (en) | 2006-05-04 | 2006-05-04 | Pharmaceutical composition of olmesartan medoxomil |
EP07724794A EP2021002B1 (en) | 2006-05-04 | 2007-05-02 | Pharmaceutical composition comprising olmesartan medoxomil |
PCT/EP2007/003868 WO2007128478A2 (en) | 2006-05-04 | 2007-05-02 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2021002T1 true SI2021002T1 (sl) | 2012-10-30 |
Family
ID=37076372
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200631227T SI1891952T1 (sl) | 2006-05-04 | 2006-05-04 | Farmacevtski sestavek, ki vsebuje olmesartan medoksomil |
SI200731003T SI2021002T1 (sl) | 2006-05-04 | 2007-05-02 | Farmacevtski sestavek, ki vsebuje olmesartan medoksomil |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200631227T SI1891952T1 (sl) | 2006-05-04 | 2006-05-04 | Farmacevtski sestavek, ki vsebuje olmesartan medoksomil |
Country Status (8)
Country | Link |
---|---|
US (1) | US9707178B2 (sl) |
EP (2) | EP1891952B1 (sl) |
AT (1) | ATE526963T1 (sl) |
CA (1) | CA2651138C (sl) |
ES (1) | ES2388880T3 (sl) |
PL (1) | PL2021002T3 (sl) |
SI (2) | SI1891952T1 (sl) |
WO (1) | WO2007128478A2 (sl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101628028B1 (ko) | 2006-06-27 | 2016-06-08 | 다이이찌 산쿄 가부시키가이샤 | 압축 제제 |
EP2228066A1 (en) * | 2009-03-03 | 2010-09-15 | LEK Pharmaceuticals d.d. | Pharmaceutical compositions of sulphonylurea-based active pharmaceutical ingredient with excellent dissolution properties |
WO2011045760A2 (en) * | 2009-10-13 | 2011-04-21 | Ranbaxy Laboratories Limited | Micronized olmesartan medoxomil compositions |
WO2011083112A2 (en) | 2010-01-05 | 2011-07-14 | Ratiopharm Gmbh | Solid oral dosage form containing olmesartan medoxomil |
TR201005867A1 (tr) | 2010-07-16 | 2012-02-21 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Olmesartan farmasötik bileşimleri. |
JP5705562B2 (ja) * | 2011-01-25 | 2015-04-22 | 沢井製薬株式会社 | カンデサルタンシレキセチル含有錠剤及びその製造方法 |
WO2014002011A1 (en) * | 2012-06-26 | 2014-01-03 | Micro Labs Limited | Micronized particles of olmesartan medoxomil and pharmaceutical composition thereof |
WO2014188729A1 (ja) * | 2013-05-24 | 2014-11-27 | 持田製薬株式会社 | 経口用組成物 |
JP6653116B2 (ja) * | 2014-08-27 | 2020-02-26 | 日本ケミファ株式会社 | オルメサルタンのプロドラッグ製剤 |
CN107998097B (zh) * | 2018-01-17 | 2018-08-31 | 扬子江药业集团上海海尼药业有限公司 | 一种含奥美沙坦酯的片剂及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1170214B (it) * | 1983-09-12 | 1987-06-03 | Crinos Industria Farmaco | Composizione farmaceutica per la cura delle arteriopatie periferiche |
IS1756B (is) | 1991-02-21 | 2000-12-28 | Sankyo Company Limited | Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða |
US6555139B2 (en) * | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
US6833381B2 (en) * | 2000-02-18 | 2004-12-21 | Takeda Chemical Industries, Ltd. | TNF-α inhibitors |
ES2262689T3 (es) * | 2000-11-21 | 2006-12-01 | Sankyo Company, Limited | Composicion que contiene un antagonista del receptor de angiotensina ii y un diuretico y su uso para el tratamiento de la hipertension. |
EP1604664A4 (en) * | 2003-01-31 | 2006-12-27 | Sankyo Co | MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS AND BLOOD HIGH PRESSURE |
GB0325291D0 (en) * | 2003-10-29 | 2003-12-03 | Pfizer Ltd | Novel combination |
EP1776095A1 (en) * | 2004-06-23 | 2007-04-25 | Solvay Pharmaceuticals GmbH | Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists |
US20070054948A1 (en) * | 2004-09-02 | 2007-03-08 | Lilach Hedvati | Purification of olmesartan medoxomil |
WO2006029057A1 (en) * | 2004-09-02 | 2006-03-16 | Teva Pharmaceutical Industries, Ltd. | Purification of olmesartan medoxomil |
AU2005298986A1 (en) * | 2004-10-27 | 2006-05-04 | F. Hoffmann-La Roche Ag | New indole or benzimidazole derivatives |
US20060281800A1 (en) * | 2005-04-12 | 2006-12-14 | Glenmark Pharmaceuticals Limited | Polymorphic form of olmesartan and process for its preparation |
CA2616466A1 (en) * | 2005-07-29 | 2007-02-15 | Krka | Process for the preparation of olmesartan medoxomil |
-
2006
- 2006-05-04 SI SI200631227T patent/SI1891952T1/sl unknown
- 2006-05-04 EP EP06009223A patent/EP1891952B1/en not_active Not-in-force
- 2006-05-04 AT AT06009223T patent/ATE526963T1/de not_active IP Right Cessation
-
2007
- 2007-05-02 PL PL07724794T patent/PL2021002T3/pl unknown
- 2007-05-02 US US12/299,237 patent/US9707178B2/en not_active Expired - Fee Related
- 2007-05-02 WO PCT/EP2007/003868 patent/WO2007128478A2/en active Application Filing
- 2007-05-02 SI SI200731003T patent/SI2021002T1/sl unknown
- 2007-05-02 EP EP07724794A patent/EP2021002B1/en not_active Not-in-force
- 2007-05-02 ES ES07724794T patent/ES2388880T3/es active Active
- 2007-05-02 CA CA2651138A patent/CA2651138C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1891952A1 (en) | 2008-02-27 |
CA2651138A1 (en) | 2007-11-15 |
EP2021002B1 (en) | 2012-05-30 |
ES2388880T3 (es) | 2012-10-19 |
WO2007128478A3 (en) | 2008-02-07 |
SI1891952T1 (sl) | 2012-02-29 |
WO2007128478A2 (en) | 2007-11-15 |
EP1891952B1 (en) | 2011-10-05 |
EP2021002A2 (en) | 2009-02-11 |
CA2651138C (en) | 2016-02-16 |
US20090238871A1 (en) | 2009-09-24 |
PL2021002T3 (pl) | 2012-11-30 |
US9707178B2 (en) | 2017-07-18 |
ATE526963T1 (de) | 2011-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2021002T1 (sl) | Farmacevtski sestavek, ki vsebuje olmesartan medoksomil | |
BR112012011328A2 (pt) | inibidores de akt | |
MX2010004493A (es) | Compuestos de tropano. | |
MY148429A (en) | Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof | |
UA102534C2 (en) | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]-dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid | |
GEP20146102B (en) | Compounds and compositions as protein kinase inhibitors | |
WO2008030744A3 (en) | Inhibitors of c-met and uses thereof | |
TW200611897A (en) | Organic compounds | |
MA32776B1 (fr) | Inhibiteurs de l'akt et de la p70 s6 kinase | |
MX2010002341A (es) | Derivados de bencimidazol usados como agonistas del receptor x de farnesoide. | |
WO2008098978A3 (en) | Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor | |
MX2011008360A (es) | Derivados de piridazinona sustituida con heteroarilo. | |
WO2009074247A8 (de) | Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel | |
NO20085317L (no) | Imidazoazepinonforbindelser | |
WO2007130821A3 (en) | Mglur5 modulators ii | |
WO2010047592A3 (en) | Preservation mixture and use thereof | |
WO2009062874A3 (en) | Benzimidazole derivatives and their use as fxr agonists | |
MX2009008221A (es) | Antagonista de receptor de cromeno s1p1. | |
WO2007095021A3 (en) | Novel compounds | |
WO2011047055A8 (en) | Novel mek inhibitors, useful in the treatment of diseases | |
WO2008098143A3 (en) | Antimicrobial compounds and methods of use | |
DE602007005387D1 (de) | Ptors | |
WO2010059639A3 (en) | Hydroxyadamantyl inhibitors of dipeptidylpeptidase iv | |
TW200738703A (en) | 2-Carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
WO2007145563A8 (en) | Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor |